Finepoint Capital »

Churchill Capital Corp V A shares owned by Finepoint Capital

Quarter-by-quarter ownership of Churchill Capital Corp V A shares owned by Finepoint Capital from 13F filings

Historical chart of Finepoint Capital investment in Churchill Capital Corp V A

Tip: Access up to 7 years of quarterly data

All positions including Churchill Capital Corp V A held by Finepoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Churchill Capital Corp V A by Finepoint Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $0 612k 0.00
2023-06-30 $110k 612k 0.18
2023-03-31 $114k 612k 0.19
2022-12-31 $49k 612k 0.08
2022-09-30 $52k 612k 0.09
2022-06-30 $202k 612k 0.33
2022-03-31 $373k 612k 0.61
2021-12-31 $600k 612k 0.98
2021-09-30 $796k 612k 1.30

More positions owned by Finepoint Capital

Moonlake Immunotherapeutics Class A Ord (MLTX)
Amicus Therapeutics (FOLD)
Sarepta Therapeutics (SRPT)
Prothena Corp SHS (PRTA)
Galapagos Nv Spon Adr (GLPG)
Ascendis Pharma A/s Sponsored Adr (ASND)
Springworks Therapeutics (SWTX)
Cytokinetics Com New (CYTK)
Cerevel Therapeutics Hldng I (CERE)
Revolution Medicines (RVMD)
ACADIA Pharmaceuticals (ACAD)
Arvinas Ord (ARVN)
Travere Therapeutics (TVTX)
Morphic Hldg (MORF)
Relay Therapeutics (RLAY)

View all positions for Finepoint Capital

Top funds holding Churchill Capital Corp V A

Birch Grove Capital

View all funds holding Churchill Capital Corp V A